{"id":"NCT02772965","sponsor":"University of North Carolina, Chapel Hill","briefTitle":"Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy","officialTitle":"A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Pragmatic Clinical Trial To Evaluate The Effectiveness Of Low Dose Oral Methotrexate In Patients With Pediatric Crohn's Disease Initiating Anti-TNF Therapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-10","primaryCompletion":"2022-04-07","completion":"2022-04-07","firstPosted":"2016-05-16","resultsPosted":"2023-04-12","lastUpdate":"2023-04-12"},"enrollment":306,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Pediatric Crohn's Disease"],"interventions":[{"type":"DRUG","name":"Methotrexate","otherNames":["Methotrexate Sodium"]},{"type":"OTHER","name":"Sugar pill (placebo)","otherNames":[]}],"arms":[{"label":"Methotrexate","type":"EXPERIMENTAL"},{"label":"Sugar pill (placebo)","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine whether adding low dose methotrexate to anti -TNF therapy is more effective than treatment with anti-TNF therapy alone in inducing and maintaining steroid-free remission for children with Crohn's Disease.","primaryOutcome":{"measure":"Percent of Participants Experiencing Treatment Failure","timeFrame":"From randomization until treatment failure, assessed up to 3 years.","effectByArm":[{"arm":"Methotrexate","deltaMin":25.64,"sd":null},{"arm":"Sugar Pill (Placebo)","deltaMin":34.04,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.08"}]},"eligibility":{"minAge":null,"sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":22},"locations":{"siteCount":32,"countries":["United States"]},"refs":{"pmids":["37004887"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":23,"n":156},"commonTop":["Nausea","Abdominal Discomfort","Rash","Headache","Elevation of Liver Enzymes (AST, ALT)"]}}